Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer

Liquid biopsy is a minimally invasive method for detecting soluble factors, including circulating tumor DNA (ctDNA), in body fluids. ctDNA carrying tumor-specific genetic or epigenetic alterations is released into circulation from tumor cells. ctDNA in the plasma contains somatic mutations that have...

Descripción completa

Detalles Bibliográficos
Autores principales: Osumi, Hiroki, Shinozaki, Eiji, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352651/
https://www.ncbi.nlm.nih.gov/pubmed/32545750
http://dx.doi.org/10.3390/cancers12061566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352651/
https://www.ncbi.nlm.nih.gov/pubmed/32545750
http://dx.doi.org/10.3390/cancers12061566

Ejemplares similares